RxDoctor Payments Data

Liza Wu, MD

Plastic Surgery · Boca Raton, FLNPI 1942234018

Payments from drug & device makers

What this record shows

The money is spread across several categories — speaking fees (35.3%), other and food and beverage — rather than concentrated in one kind of arrangement. 10 manufacturers reported payments, led by Integra Lifesciences Corporation at 40.7% of the total. 2025 is the largest year on record at $1,416, more than ten times the $35 reported in 2019.

$3,398in general payments, 2019–2025

Across 22 payments — averaging $154.45 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Integra Lifesciences Corporation$1K
  • RTI Surgical, Inc$1K
  • Sientra, Inc.$207
  • Johnson & Johnson$123
  • Davol Inc.$100
  • TELA Bio, Inc.$93
  • plus $294 from 4 others
$77,625in research payments, 2019–2025

Across 127 payments — averaging $611.22 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Mentor Worldwide LLC$70K
  • Medical Device Business Services, Inc.$8K

What the payments were for

  • Speaking & faculty fees$1,20035%
  • Food & beverage$1,09632%
  • Other$1,10232%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,398 in reported general payments places this provider in the 60th percentile of 456 plastic surgery providers in Florida.

See all plastic surgery providers in Florida

Medicare billing

Part B allowed, 2024
$87,333
Medicare patients
62
Services billed
168

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Cefadroxil34$173
Gabapentin11$77
Tramadol Hcl37$66

Paid to pharmacies, not to this prescriber.

Other plastic surgery in Boca Raton

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →